VivoSeq
Other

Irrigation

0

Pipeline Programs

4

Active Trials

2

Companies Involved

Irrigation is an early-stage landscape with 0 programs across 2 companies. The most active players are Diceros Therapeutics, NovaBay Pharmaceuticals, Inc..

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

18/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

22

clinical trials

Completed8 · 36%
Unknown status6 · 27%
Terminated4 · 18%
Recruiting3 · 14%
Active, not recruiting1 · 5%

Trial Activity

22 trials

Antibiotic Irrigations for Intra-Abdominal Drains
Recruiting··Phase 2·NCT03476941·50 enrolled
Antibiotic Irrigation for Pancreatoduodenectomy
Completed·IIndiana University·N/A·NCT02186457·190 enrolled
Chlorine Dioxide Versus Saline for Wound Irrigation
Completed·RRhode Island Hospital·Phase 1·NCT01341041·201 enrolled
SynRinse Irrigation Pilot (SIP) Trial
Completed·UUniversity of Washington·Phase 1/2·NCT03154541·30 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)